{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:17:09Z","timestamp":1790299029360,"version":"4.1.0"},"publisher-location":"Cham","reference-count":96,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030971816","type":"print"},{"value":"9783030971823","type":"electronic"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-3-030-97182-3_4","type":"book-chapter","created":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T12:18:25Z","timestamp":1659701905000},"page":"53-63","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Schizophrenia Outside the Brain"],"prefix":"10.1007","author":[{"given":"Aline Gazzola Fragnani","family":"Valen\u00e7a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley Joseph","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,6]]},"reference":[{"issue":"9","key":"4_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0257129","volume":"16","author":"T Ali","year":"2021","unstructured":"Ali, T., Sisay, M., Tariku, M., Mekuria, A. N., & Desalew, A. (2021). Antipsychotic-induced extrapyramidal side effects: A systematic review and meta-analysis of observational studies. PLoS One, 16(9), e0257129.","journal-title":"PLoS One"},{"issue":"5","key":"4_CR2","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1001\/archpsyc.1995.03950170015003","volume":"52","author":"NC Andreasen","year":"1995","unstructured":"Andreasen, N. C., Arndt, S., Alliger, R., Miller, D., & Flaum, M. (1995). Symptoms of schizophrenia. Methods, meanings, and mechanisms. Archives of General Psychiatry, 52(5), 341\u2013351.","journal-title":"Archives of General Psychiatry"},{"issue":"1-3","key":"4_CR3","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.schres.2011.10.026","volume":"136","author":"I Arias","year":"2012","unstructured":"Arias, I., Sorlozano, A., Villegas, E., de Dios Luna, J., McKenney, K., Cervilla, J., Gutierrez, B., & Gutierrez, J. (2012). Infectious agents associated with schizophrenia: A meta-analysis. Schizophrenia Research, 136(1-3), 128\u2013136.","journal-title":"Schizophrenia Research"},{"issue":"10","key":"4_CR4","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1185\/03007995.2010.515900","volume":"26","author":"H Ascher-Svanum","year":"2010","unstructured":"Ascher-Svanum, H., Nyhuis, A. W., Stauffer, V., Kinon, B. J., Faries, D. E., Phillips, G. A., Kory, S., George Awad, A., Keefe, R., & Naber, D. (2010). Reasons for discontinuation and continuation of antipsychotics in the treatment of schizophrenia from patient and clinician perspectives. Current Medical Research and Opinion, 26(10), 2403\u20132410.","journal-title":"Current Medical Research and Opinion"},{"issue":"September","key":"4_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jpsychores.2017.07.004","volume":"100","author":"AL Bahorik","year":"2017","unstructured":"Bahorik, A. L., Satre, D. D., Kline-Simon, A. H., Weisner, C. M., & Campbell, C. I. (2017). Serious mental illness and medical comorbidities: Findings from an integrated health care system. Journal of Psychosomatic Research, 100(September), 35\u201345.","journal-title":"Journal of Psychosomatic Research"},{"key":"4_CR6","first-page":"141","volume-title":"Neuroinflammation and Schizophrenia","author":"ME Benros","year":"2020","unstructured":"Benros, M. E., & Mortensen, P. B. (2020). Role of infection, autoimmunity, atopic disorders, and the immune system in schizophrenia: Evidence from epidemiological and genetic studies. In G. M. Khandaker, U. Meyer, & P. B. Jones (Eds.), Neuroinflammation and Schizophrenia (pp. 141\u2013159). Springer International Publishing."},{"key":"4_CR7","doi-asserted-by":"publisher","unstructured":"Birnbaum, R., & Weinberger, D.R. (2020). A genetics perspective on the role of the (neuro)immune system in schizophrenia. Schizophrenia Research. https:\/\/doi.org\/10.1016\/j.schres.2019.02.005.","DOI":"10.1016\/j.schres.2019.02.005"},{"issue":"3","key":"4_CR8","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/schbul\/sbz076","volume":"46","author":"EM Blessing","year":"2020","unstructured":"Blessing, E. M., Murty, V. P., Zeng, B., Wang, J., Davachi, L., & Goff, D. C. (2020). Anterior hippocampal-cortical functional connectivity distinguishes antipsychotic Na\u00efve first-episode psychosis patients from controls and may predict response to second-generation antipsychotic treatment. Schizophrenia Bulletin, 46(3), 680\u2013689.","journal-title":"Schizophrenia Bulletin"},{"issue":"8","key":"4_CR9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s11920-019-1050-z","volume":"21","author":"PF Buckley","year":"2019","unstructured":"Buckley, P. F. (2019). Neuroinflammation and schizophrenia. Current Psychiatry Reports, 21(8), 72.","journal-title":"Current Psychiatry Reports"},{"issue":"1","key":"4_CR10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ncl.2010.10.002","volume":"29","author":"SN Caroff","year":"2011","unstructured":"Caroff, S. N., Hurford, I., Lybrand, J., & Cabrina Campbell, E. (2011). Movement disorders induced by antipsychotic drugs: Implications of the CATIE schizophrenia trial. Neurologic Clinics, 29(1), 127\u2013148, viii.","journal-title":"Neurologic Clinics"},{"issue":"1","key":"4_CR11","doi-asserted-by":"publisher","first-page":"10901","DOI":"10.1038\/s41598-017-11323-9","volume":"7","author":"C-C Chen","year":"2017","unstructured":"Chen, C.-C., Hsu, L.-W., Huang, K.-T., Goto, S., Chen, C.-L., & Nakano, T. (2017). Overexpression of Insig-2 inhibits atypical antipsychotic-induced adipogenic differentiation and lipid biosynthesis in adipose-derived stem cells. Scientific Reports, 7(1), 10901.","journal-title":"Scientific Reports"},{"key":"4_CR12","doi-asserted-by":"publisher","first-page":"605124","DOI":"10.3389\/fpsyt.2020.605124","volume":"11","author":"CY-A Chen","year":"2021","unstructured":"Chen, C. Y.-A., Goh, K. K., Chen, C.-H., & Mong-Liang, L. (2021). The role of adiponectin in the pathogenesis of metabolic disturbances in patients with schizophrenia. Frontiers in Psychiatry, 11, 605124. https:\/\/doi.org\/10.3389\/fpsyt.2020.605124","journal-title":"Frontiers in Psychiatry"},{"issue":"1","key":"4_CR13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s40501-018-0138-0","volume":"5","author":"S Conroy","year":"2018","unstructured":"Conroy, S., Francis, M., & Hulvershorn, L. A. (2018). Identifying and treating the prodromal phases of bipolar disorder and schizophrenia. Current Treatment Options in Psychiatry, 5(1), 113\u2013128.","journal-title":"Current Treatment Options in Psychiatry"},{"issue":"2","key":"4_CR14","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/wps.20516","volume":"17","author":"CU Correll","year":"2018","unstructured":"Correll, C. U., Rubio, J. M., & Kane, J. M. (2018). What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia? World Psychiatry, 17(2), 149\u2013160.","journal-title":"World Psychiatry"},{"issue":"5","key":"4_CR15","first-page":"803","volume":"14","author":"JW Crayton","year":"1979","unstructured":"Crayton, J. W., & Meltzer, H. Y. (1979). Degeneration and regeneration of motor neurons in psychotic patients. Biological Psychiatry, 14(5), 803\u2013819.","journal-title":"Biological Psychiatry"},{"issue":"2-3","key":"4_CR16","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.schres.2003.12.007","volume":"70","author":"J Danckert","year":"2004","unstructured":"Danckert, J., Saoud, M., & Maruff, P. (2004). Attention, motor control and motor imagery in schizophrenia: Implications for the role of the parietal cortex. Schizophrenia Research, 70(2-3), 241\u2013261.","journal-title":"Schizophrenia Research"},{"key":"4_CR17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.schres.2015.05.004","volume":"166","author":"AE Darcin","year":"2015","unstructured":"Darcin, A. E., Cavus, S. Y., Dilbaz, N., Kaya, H., & Dogan, E. (2015). Metabolic syndrome in drug-Na\u00efve and drug-free patients with schizophrenia and in their siblings. Schizophrenia Research, 166, 201\u2013206. https:\/\/doi.org\/10.1016\/j.schres.2015.05.004","journal-title":"Schizophrenia Research"},{"key":"4_CR18","doi-asserted-by":"publisher","unstructured":"De Hert, M., Mittoux, A., He, Y., & Peuskens, J. (2011). Metabolic parameters in the short- and long-term treatment of schizophrenia with Sertindole or Risperidone. European Archives of Psychiatry and Clinical Neuroscience. https:\/\/doi.org\/10.1007\/s00406-010-0142-x","DOI":"10.1007\/s00406-010-0142-x"},{"issue":"1","key":"4_CR19","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s12888-016-1049-5","volume":"16","author":"VA de Silva","year":"2016","unstructured":"de Silva, V. A., Suraweera, C., Ratnatunga, S. S., Dayabandara, M., Wanniarachchi, N., & Hanwella, R. (2016). Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis. BMC Psychiatry, 16(1), 341.","journal-title":"BMC Psychiatry"},{"key":"4_CR20","doi-asserted-by":"crossref","unstructured":"Dias, I. C. S., de Campos-Carli, S. M., Vieira, E. L. M., Mota, A. P. L., Azevedo, P. S., da Silveira An\u00edcio, V. T., & Salgado, J. V. (2021). Adiponectin and Stnfr2 peripheral levels are associated with cardiovascular risk in patients with schizophrenia.\u00a0Journal of Psychiatric Research. 10.1016\/j.jpsychires.2021.11.020.","DOI":"10.1016\/j.jpsychires.2021.11.020"},{"issue":"1-3","key":"4_CR21","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.schres.2008.04.017","volume":"103","author":"E Fernandez-Egea","year":"2008","unstructured":"Fernandez-Egea, E., Bernardo, M., Parellada, E., Justicia, A., Garcia-Rizo, C., Esmatjes, E., Conget, I., & Kirkpatrick, B. (2008). Glucose abnormalities in the siblings of people with schizophrenia. Schizophrenia Research, 103(1-3), 110\u2013113.","journal-title":"Schizophrenia Research"},{"issue":"7612","key":"4_CR22","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nature18626","volume":"535","author":"AJ Filiano","year":"2016","unstructured":"Filiano, A. J., Xu, Y., Tustison, N. J., Marsh, R. L., Baker, W., Smirnov, I., & Christopher C. Overall, et al. (2016). Unexpected role of interferon-\u03b3 in regulating neuronal connectivity and social behaviour. Nature, 535(7612), 425\u2013429.","journal-title":"Nature"},{"key":"4_CR23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/978-3-030-29450-2_15","volume-title":"psychotic disorders: a practical guide","author":"O Freudenreich","year":"2020","unstructured":"Freudenreich, Oliver. 2020. \u201cAntipsychotics: Nonmotor Side Effects.\u201d In psychotic disorders: a practical guide Oliver Freudenreich, 201\u2013214. : Springer International Publishing."},{"issue":"1","key":"4_CR24","first-page":"56","volume":"49","author":"SJ Girdler","year":"2019","unstructured":"Girdler, S. J., Confino, J. E., & Woesner, M. E. (2019). Exercise as a treatment for schizophrenia: A review. Psychopharmacology Bulletin, 49(1), 56\u201369.","journal-title":"Psychopharmacology Bulletin"},{"key":"4_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-12668-1","volume-title":"Reviews on Biomarker Studies of Metabolic and Metabolism-Related Disorders","author":"PC Guest","year":"2019","unstructured":"Guest, Paul C. 2019. \u201cInsulin Resistance in Schizophrenia.\u201d In Reviews on Biomarker Studies of Metabolic and Metabolism-Related Disorders Paul C. Guest, 1\u201316. : Springer International Publishing."},{"issue":"August","key":"4_CR26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ajp.2018.06.018","volume":"36","author":"J Gurusamy","year":"2018","unstructured":"Gurusamy, J., Gandhi, S., Damodharan, D., Ganesan, V., & Palaniappan, M. (2018). Exercise, diet and educational interventions for metabolic syndrome in persons with schizophrenia: A systematic review. Asian Journal of Psychiatry, 36(August), 73\u201385.","journal-title":"Asian Journal of Psychiatry"},{"issue":"4","key":"4_CR27","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/jep.12917","volume":"24","author":"S Haralanov","year":"2018","unstructured":"Haralanov, S., Haralanova, E., Milushev, E., Shkodrova, D., & Claussen, C.-F. (2018). Objective and quantitative Equilibriometric evaluation of individual locomotor behaviour in schizophrenia: translational and clinical implications. Journal of Evaluation in Clinical Practice, 24(4), 815\u2013825.","journal-title":"Journal of Evaluation in Clinical Practice"},{"issue":"December","key":"4_CR28","doi-asserted-by":"publisher","first-page":"110370","DOI":"10.1016\/j.pnpbp.2021.110370","volume":"111","author":"D Hirjak","year":"2021","unstructured":"Hirjak, D., Meyer-Lindenberg, A., Sambataro, F., Fritze, S., Kukovic, J., Kubera, K. M., & Wolf, R. C. (2021). Progress in sensorimotor neuroscience of schizophrenia Spectrum disorders: Lessons learned and future directions. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 111(December), 110370.","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"issue":"1","key":"4_CR29","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s12888-018-1848-y","volume":"18","author":"S Ijaz","year":"2018","unstructured":"Ijaz, S., Bolea, B., Davies, S., Savovi\u0107, J., Richards, A., Sullivan, S., & Moran, P. (2018). Antipsychotic polypharmacy and metabolic syndrome in schizophrenia: A review of systematic reviews. BMC Psychiatry, 18(1), 275.","journal-title":"BMC Psychiatry"},{"key":"4_CR30","doi-asserted-by":"publisher","unstructured":"Ilani, T., Strous, R. D., & Fuchs, S. (2004). Dopaminergic regulation of immune cells via D 3 dopamine receptor: A pathway mediated by activated T cells. The FASEB Journal. https:\/\/doi.org\/10.1096\/fj.04-1652fje","DOI":"10.1096\/fj.04-1652fje"},{"issue":"10","key":"4_CR31","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.3390\/ijms18102174","volume":"18","author":"SW Jeon","year":"2017","unstructured":"Jeon, S. W., & Kim, Y.-K. (2017). Unresolved issues for utilization of atypical antipsychotics in schizophrenia: Antipsychotic polypharmacy and metabolic syndrome. International Journal of Molecular Sciences, 18(10), 2174. https:\/\/doi.org\/10.3390\/ijms18102174","journal-title":"International Journal of Molecular Sciences"},{"issue":"1-3","key":"4_CR32","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.schres.2007.05.009","volume":"95","author":"JM Kane","year":"2007","unstructured":"Kane, J. M., Crandall, D. T., Marcus, R. N., Eudicone, J., Pikalov, A., 3rd, Carson, W. H., & Swyzen, W. (2007). Symptomatic remission in schizophrenia patients treated with aripiprazole or haloperidol for up to 52 weeks. Schizophrenia Research, 95(1-3), 143\u2013150.","journal-title":"Schizophrenia Research"},{"issue":"2","key":"4_CR33","doi-asserted-by":"publisher","first-page":"185","DOI":"10.31887\/DCNS.2014.16.2\/akarow","volume":"16","author":"A Karow","year":"2014","unstructured":"Karow, A., Wittmann, L., Sch\u00f6ttle, D., Sch\u00e4fer, I., & Lambert, M. (2014). The assessment of quality of life in clinical practice in patients with schizophrenia. Dialogues in Clinical Neuroscience, 16(2), 185\u2013195.","journal-title":"Dialogues in Clinical Neuroscience"},{"issue":"2","key":"4_CR34","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1017\/S0033291712000736","volume":"43","author":"GM Khandaker","year":"2013","unstructured":"Khandaker, G. M., Zimbron, J., Lewis, G., & Jones, P. B. (2013). Prenatal maternal infection, neurodevelopment and adult schizophrenia: A systematic review of population-based studies. Psychological Medicine, 43(2), 239\u2013257.","journal-title":"Psychological Medicine"},{"issue":"21","key":"4_CR35","doi-asserted-by":"publisher","first-page":"8180","DOI":"10.1073\/pnas.0402268101","volume":"101","author":"J Kipnis","year":"2004","unstructured":"Kipnis, J., Cohen, H., Cardon, M., Ziv, Y., & Schwartz, M. (2004). T cell deficiency leads to cognitive dysfunction: Implications for therapeutic vaccination for schizophrenia and other psychiatric conditions. Proceedings of the National Academy of Sciences of the United States of America, 101(21), 8180\u20138185.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"4_CR36","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1093\/schbul\/sbt141","volume":"39","author":"B Kirkpatrick","year":"2013","unstructured":"Kirkpatrick, B., & Miller, B. J. (2013). Inflammation and schizophrenia. Schizophrenia Bulletin, 39(6), 1174\u20131179.","journal-title":"Schizophrenia Bulletin"},{"issue":"2","key":"4_CR37","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/mp.2011.154","volume":"17","author":"G Kirov","year":"2012","unstructured":"Kirov, G., Pocklington, A. J., Holmans, P., Ivanov, D., Ikeda, M., Ruderfer, D., Moran, J., et al. (2012). De Novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Molecular Psychiatry, 17(2), 142\u2013153.","journal-title":"Molecular Psychiatry"},{"issue":"1","key":"4_CR38","doi-asserted-by":"publisher","first-page":"3769","DOI":"10.1038\/s41467-018-06118-z","volume":"9","author":"AM Kopec","year":"2018","unstructured":"Kopec, A. M., Smith, C. J., Ayre, N. R., Sweat, S. C., & Bilbo, S. D. (2018). Microglial dopamine receptor elimination defines sex-specific nucleus accumbens development and social behavior in adolescent rats. Nature Communications, 9(1), 3769.","journal-title":"Nature Communications"},{"issue":"October","key":"4_CR39","doi-asserted-by":"publisher","first-page":"105344","DOI":"10.1016\/j.psyneuen.2021.105344","volume":"132","author":"X Lang","year":"2021","unstructured":"Lang, X., Yang, Z., Zhao, L., Yinjun, G., Wu, X., Zhao, Y., Li, Z., & Zhang, X. (2021). Differences in patterns of metabolic abnormality and metabolic syndrome between early-onset and adult-onset first-episode drug-naive schizophrenia patients. Psychoneuroendocrinology, 132(October), 105344.","journal-title":"Psychoneuroendocrinology"},{"issue":"7499","key":"4_CR40","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nature13154","volume":"509","author":"H Lee","year":"2014","unstructured":"Lee, H., Brott, B. K., Kirkby, L. A., Adelson, J. D., Cheng, S., Feller, M. B., Datwani, A., & Shatz, C. J. (2014). Synapse elimination and learning rules co-regulated by MHC Class I H2-Db. Nature, 509(7499), 195\u2013200.","journal-title":"Nature"},{"key":"4_CR41","doi-asserted-by":"publisher","unstructured":"Lehmann, M. L., Weigel, T. K., Poffenberger, C. N., & Herkenham, M. (2019). The behavioral sequelae of social defeat require microglia and are driven by oxidative stress in mice.\u00a0The Journal of Neuroscience. https:\/\/doi.org\/10.1523\/jneurosci.0184-19.2019","DOI":"10.1523\/jneurosci.0184-19.2019"},{"issue":"4","key":"4_CR42","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2165\/00023210-200418040-00005","volume":"18","author":"JA Lieberman","year":"2004","unstructured":"Lieberman, J. A. (2004). Dopamine partial agonists: A new class of antipsychotic. CNS Drugs, 18(4), 251\u2013267.","journal-title":"CNS Drugs"},{"issue":"January","key":"4_CR43","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jpsychires.2015.10.008","volume":"72","author":"D L\u00f6ffler","year":"2016","unstructured":"L\u00f6ffler, D., Landgraf, K., K\u00f6rner, A., Kratzsch, J., Kirkby, K. C., & Himmerich, H. (2016). Modulation of triglyceride accumulation in adipocytes by psychopharmacological agents in vitro. Journal of Psychiatric Research, 72(January), 37\u201342.","journal-title":"Journal of Psychiatric Research"},{"key":"4_CR44","doi-asserted-by":"publisher","unstructured":"MacDowell, K. S., Caso, J. R., Mart\u00edn-Hern\u00e1ndez, D., Madrigal, J. L., Leza, J. C., & Garc\u00eda-Bueno, B. (2015). Paliperidone prevents brain toll-like receptor 4 pathway activation and Neuroinflammation in rat models of acute and chronic restraint stress.\u00a0International Journal of Neuropsychopharmacology. https:\/\/doi.org\/10.1093\/ijnp\/pyu070","DOI":"10.1093\/ijnp\/pyu070"},{"issue":"December","key":"4_CR45","first-page":"622","volume":"9","author":"NE MacKenzie","year":"2018","unstructured":"MacKenzie, N. E., Kowalchuk, C., Agarwal, S. M., Costa-Dookhan, K. A., Caravaggio, F., Gerretsen, P., Chintoh, A., et al. (2018). Antipsychotics, metabolic adverse effects, and cognitive function in schizophrenia. Frontiers in Psychiatry\/Frontiers Research Foundation, 9(December), 622.","journal-title":"Frontiers in Psychiatry\/Frontiers Research Foundation"},{"issue":"3","key":"4_CR46","doi-asserted-by":"publisher","first-page":"227","DOI":"10.4103\/0253-7176.119471","volume":"35","author":"N Malhotra","year":"2013","unstructured":"Malhotra, N., Grover, S., Chakrabarti, S., & Kulhara, P. (2013). Metabolic Syndrome in Schizophrenia. Indian Journal of Psychological Medicine, 35(3), 227\u2013240.","journal-title":"Indian Journal of Psychological Medicine"},{"issue":"1","key":"4_CR47","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00406-019-01002-3","volume":"270","author":"D Martins-de-Souza","year":"2020","unstructured":"Martins-de-Souza, D., Guest, P. C., & Steiner, J. (2020). A proteomic signature associated to atypical antipsychotic response in schizophrenia patients: A pilot study. European Archives of Psychiatry and Clinical Neuroscience, 270(1), 127\u2013134.","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"issue":"5","key":"4_CR48","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00406-019-01025-w","volume":"269","author":"I Maurus","year":"2019","unstructured":"Maurus, I., Hasan, A., R\u00f6h, A., Takahashi, S., Rauchmann, B., Keeser, D., Malchow, B., Schmitt, A., & Falkai, P. (2019). Neurobiological effects of aerobic exercise, with a focus on patients with schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, 269(5), 499\u2013515.","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"issue":"6 Suppl","key":"4_CR49","first-page":"182","volume":"151","author":"KA Menninger","year":"1994","unstructured":"Menninger, K. A. (1994). Influenza and Schizophrenia. An Analysis of Post-Influenzal \u2018Dementia Precox,\u2019 as of 1918, and Five Years Later Further Studies of the Psychiatric Aspects of Influenza. 1926. The American Journal of Psychiatry, 151(6 Suppl), 182\u2013187.","journal-title":"The American Journal of Psychiatry"},{"issue":"April","key":"4_CR50","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.pnpbp.2011.11.003","volume":"42","author":"U Meyer","year":"2013","unstructured":"Meyer, U. (2013). Developmental Neuroinflammation and Schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 42(April), 20\u201334.","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"issue":"4","key":"4_CR51","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1192\/bjp.bp.108.050088","volume":"193","author":"DD Miller","year":"2008","unstructured":"Miller, D. D., Caroff, S. N., Davis, S. M., Rosenheck, R. A., McEvoy, J. P., Saltz, B. L., Riggio, S., et al. (2008). Extrapyramidal side-effects of antipsychotics in a randomised trial. The British Journal of Psychiatry: the Journal of Mental Science, 193(4), 279\u2013288.","journal-title":"The British Journal of Psychiatry: the Journal of Mental Science"},{"issue":"4","key":"4_CR52","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/eip.12859","volume":"14","author":"D Mongan","year":"2020","unstructured":"Mongan, D., Ramesar, M., F\u00f6cking, M., Cannon, M., & Cotter, D. (2020). Role of inflammation in the pathogenesis of schizophrenia: A review of the evidence, proposed mechanisms and implications for treatment. Early Intervention in Psychiatry, 14(4), 385\u2013397.","journal-title":"Early Intervention in Psychiatry"},{"issue":"5","key":"4_CR53","first-page":"617","volume":"81","author":"J Muench","year":"2010","unstructured":"Muench, J., & Hamer, A. M. (2010). Adverse effects of antipsychotic medications. American Family Physician, 81(5), 617\u2013622.","journal-title":"American Family Physician"},{"issue":"October","key":"4_CR54","first-page":"372","volume":"9","author":"N M\u00fcller","year":"2015","unstructured":"M\u00fcller, N., Weidinger, E., Leitner, B., & Schwarz, M. J. (2015). The role of inflammation in schizophrenia. Frontiers in Neuroscience, 9(October), 372.","journal-title":"Frontiers in Neuroscience"},{"key":"4_CR55","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jneuroim.2019.02.007","volume":"332","author":"G Nasi","year":"2019","unstructured":"Nasi, G., Ahmed, T., Rasini, E., Fenoglio, D., Marino, F., Filaci, G., & Cosentino, M. (2019). Dopamine inhibits human CD8 Treg function through D1-like dopaminergic receptors. Journal of Neuroimmunology, 332, 233. https:\/\/doi.org\/10.1016\/j.jneuroim.2019.02.007","journal-title":"Journal of Neuroimmunology"},{"issue":"2","key":"4_CR56","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41569-020-00463-7","volume":"18","author":"RE Nielsen","year":"2021","unstructured":"Nielsen, R. E., Banner, J., & Jensen, S. E. (2021). Cardiovascular Disease in Patients with Severe Mental Illness. Nature Reviews. Cardiology, 18(2), 136\u2013145.","journal-title":"Nature Reviews. Cardiology"},{"issue":"4","key":"4_CR57","doi-asserted-by":"publisher","first-page":"395","DOI":"10.4103\/0971-5916.184280","volume":"143","author":"R Padmavati","year":"2016","unstructured":"Padmavati, R. (2016). Metabolic syndrome, serious mental illnesses & lifestyle. The Indian Journal of Medical Research, 143(4), 395\u2013397.","journal-title":"The Indian Journal of Medical Research"},{"issue":"5","key":"4_CR58","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00109-019-01762-4","volume":"97","author":"JH Park","year":"2019","unstructured":"Park, J. H., Park, H. J., Lee, S. E., Kim, Y. S., Jang, G.-Y., Han, H. D., Jung, I. D., et al. (2019). Repositioning of the antipsychotic drug TFP for sepsis treatment. Journal of Molecular Medicine, 97(5), 647\u2013658.","journal-title":"Journal of Molecular Medicine"},{"issue":"3","key":"4_CR59","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1001\/jamapsychiatry.2016.3803","volume":"74","author":"T Pillinger","year":"2017","unstructured":"Pillinger, T., Beck, K., Gobjila, C., Donocik, J. G., Jauhar, S., & Howes, O. D. (2017). Impaired glucose homeostasis in first-episode schizophrenia: A systematic review and meta-analysis. JAMA Psychiatry, 74(3), 261\u2013269.","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"4_CR60","doi-asserted-by":"publisher","first-page":"324","DOI":"10.4103\/0019-5545.58304","volume":"51","author":"CT Ramachandraiah","year":"2009","unstructured":"Ramachandraiah, C. T., Subramaniam, N., & Tancer, M. (2009). The story of antipsychotics: Past and present. Indian Journal of Psychiatry, 51(4), 324\u2013326.","journal-title":"Indian Journal of Psychiatry"},{"issue":"November","key":"4_CR61","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.phrs.2015.07.022","volume":"101","author":"LE Rojo","year":"2015","unstructured":"Rojo, L. E., Gaspar, P. A., Silva, H., Risco, L., Arena, P., Cubillos-Robles, K., & Jara, B. (2015). Metabolic syndrome and obesity among users of second generation antipsychotics: A global challenge for modern psychopharmacology. Pharmacological Research, 101(November), 74\u201385.","journal-title":"Pharmacological Research"},{"issue":"20","key":"4_CR62","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1001\/jama.290.20.2693","volume":"290","author":"R Rosenheck","year":"2003","unstructured":"Rosenheck, R., Perlick, D., Bingham, S., Liu-Mares, W., Collins, J., Warren, S., Leslie, D., et al. (2003). Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: A randomized controlled trial. JAMA: The Journal of the American Medical Association, 290(20), 2693\u20132702.","journal-title":"JAMA: The Journal of the American Medical Association"},{"issue":"7","key":"4_CR63","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s00406-017-0858-y","volume":"268","author":"J Ruppert","year":"2018","unstructured":"Ruppert, J., Hartung, D., Westhoff-Bleck, M., Herrmann, J., Stubbs, B., Cordes, J., Kr\u00fcger, T. H. C., Lichtinghagen, R., & Kahl, K. G. (2018). Increased pericardial adipose tissue and cardiometabolic risk in patients with schizophrenia versus healthy controls. European Archives of Psychiatry and Clinical Neuroscience, 268(7), 719\u2013725.","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"issue":"5","key":"4_CR64","doi-asserted-by":"publisher","first-page":"201","DOI":"10.9740\/mhc.2017.09.201","volume":"7","author":"SR Saklad","year":"2017","unstructured":"Saklad, S. R. (2017). Graphic representation of pharmacology: Development of an alternative model. The Mental Health Clinician, 7(5), 201\u2013206.","journal-title":"The Mental Health Clinician"},{"issue":"December","key":"4_CR65","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3389\/fpsyt.2018.00690","volume":"9","author":"A Schmitt","year":"2018","unstructured":"Schmitt, A., Maurus, I., Rossner, M. J., R\u00f6h, A., Lembeck, M., von Wilmsdorff, M., Takahashi, S., et al. (2018). Effects of aerobic exercise on metabolic syndrome, cardiorespiratory fitness, and symptoms in schizophrenia include decreased mortality. Frontiers in Psychiatry \/ Frontiers Research Foundation, 9(December), 690.","journal-title":"Frontiers in Psychiatry \/ Frontiers Research Foundation"},{"key":"4_CR66","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature16549","volume":"530","author":"A Sekar","year":"2016","unstructured":"Sekar, A., Schizophrenia Working Group of the Psychiatric Genomics Consortium, Bialas, A. R., de Rivera, H., Davis, A., Hammond, T. R., Kamitaki, N., et al. (2016). Schizophrenia risk from complex variation of complement component. Nature, 530, 177. https:\/\/doi.org\/10.1038\/nature16549","journal-title":"Nature"},{"issue":"June","key":"4_CR67","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.schres.2019.01.005","volume":"208","author":"P Shah","year":"2019","unstructured":"Shah, P., Iwata, Y., Caravaggio, F., Plitman, E., Brown, E. E., Kim, J., Chan, N., et al. (2019). Alterations in body mass index and waist-to-hip ratio in never and minimally treated patients with psychosis: A systematic review and meta-analysis. Schizophrenia Research, 208(June), 420\u2013429.","journal-title":"Schizophrenia Research"},{"issue":"6","key":"4_CR68","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/acps.13365","volume":"144","author":"E Smith","year":"2021","unstructured":"Smith, E., Singh, R., Lee, J., Colucci, L., Graff-Guerrero, A., Remington, G., Hahn, M., & Agarwal, S. M. (2021). Adiposity in schizophrenia: A systematic review and meta-analysis. Acta Psychiatrica Scandinavica, 144(6), 524\u2013536.","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"5","key":"4_CR69","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1464-5491.2007.02092.x","volume":"24","author":"LM Spelman","year":"2007","unstructured":"Spelman, L. M., Walsh, P. I., Sharifi, N., Collins, P., & Thakore, J. H. (2007). Impaired glucose tolerance in first-episode drug-Na\u00efve patients with schizophrenia. Diabetic Medicine: A Journal of the British Diabetic Association, 24(5), 481\u2013485.","journal-title":"Diabetic Medicine: A Journal of the British Diabetic Association"},{"key":"4_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41537-018-0053-9","volume":"4","author":"J Spertus","year":"2018","unstructured":"Spertus, J., Horvitz-Lennon, M., Abing, H., & Normand, S.-L. (2018). Risk of weight gain for specific antipsychotic drugs: A meta-analysis. Npj Schizophrenia, 4, 1\u20137. https:\/\/doi.org\/10.1038\/s41537-018-0053-9","journal-title":"Npj Schizophrenia"},{"key":"4_CR71","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/978-3-319-52479-5_21","volume-title":"Proteomic methods in neuropsychiatric research","author":"J Steiner","year":"2017","unstructured":"Steiner, J., & Guest, P. C. (2017). A clinical study protocol to identify serum biomarkers predictive of response to antipsychotics in schizophrenia patients. In P. C. Guest (Ed.), Proteomic methods in neuropsychiatric research (pp. 245\u2013250). Springer International Publishing."},{"issue":"2","key":"4_CR72","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/acps.12439","volume":"132","author":"B Stubbs","year":"2015","unstructured":"Stubbs, B., Vancampfort, D., De Hert, M., & Mitchell, A. J. (2015). The prevalence and predictors of type two diabetes mellitus in people with schizophrenia: A systematic review and comparative meta-analysis. Acta Psychiatrica Scandinavica, 132(2), 144\u2013157.","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"4","key":"4_CR73","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/mp.2008.125","volume":"14","author":"PF Sullivan","year":"2009","unstructured":"Sullivan, P. F., de Geus, E. J. C., Willemsen, G., James, M. R., Smit, J. H., Zandbelt, T., Arolt, V., et al. (2009). Genome-wide Association for Major Depressive Disorder: A possible role for the presynaptic protein piccolo. Molecular Psychiatry, 14(4), 359\u2013375.","journal-title":"Molecular Psychiatry"},{"issue":"2","key":"4_CR74","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11892-015-0704-4","volume":"16","author":"J Suvisaari","year":"2016","unstructured":"Suvisaari, J., Kein\u00e4nen, J., Eskelinen, S., & Mantere, O. (2016). Diabetes and Schizophrenia. Current Diabetes Reports, 16(2), 16.","journal-title":"Current Diabetes Reports"},{"issue":"1","key":"4_CR75","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/s41467-017-00716-z","volume":"8","author":"DA Sykes","year":"2017","unstructured":"Sykes, D. A., Moore, H., Stott, L., Holliday, N., Javitch, J. A., Robert Lane, J., & Charlton, S. J. (2017). Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors. Nature Communications, 8(1), 763.","journal-title":"Nature Communications"},{"issue":"July","key":"4_CR76","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12991-020-00292-5","volume":"19","author":"R Tandon","year":"2020","unstructured":"Tandon, R., Lenderking, W. R., Weiss, C., Shalhoub, H., Barbosa, C. D., Chen, J., Greene, M., et al. (2020). The impact on functioning of second-generation antipsychotic medication side effects for patients with schizophrenia: A worldwide, cross-sectional, web-based survey. Annals of General Psychiatry, 19(July), 42.","journal-title":"Annals of General Psychiatry"},{"issue":"July","key":"4_CR77","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.bbi.2015.09.001","volume":"55","author":"L Torres","year":"2016","unstructured":"Torres, L., Danver, J., Ji, K., Miyauchi, J. T., Chen, D., Anderson, M. E., West, B. L., Robinson, J. K., & Tsirka, S. E. (2016). Dynamic microglial modulation of spatial learning and social behavior. Brain, Behavior, and Immunity, 55(July), 6\u201316.","journal-title":"Brain, Behavior, and Immunity"},{"issue":"6","key":"4_CR78","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/nri2566","volume":"9","author":"KJ Tracey","year":"2009","unstructured":"Tracey, K. J. (2009). Reflex Control of Immunity. Nature Reviews. Immunology, 9(6), 418\u2013428.","journal-title":"Nature Reviews. Immunology"},{"issue":"7","key":"4_CR79","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.3390\/jcm9072189","volume":"9","author":"S Tyrovolas","year":"2020","unstructured":"Tyrovolas, S., Moneta, V., V\u00e1zquez, I. G., Koyanagi, A., Abduljabbar, A. S., & Haro, J. M. (2020). Mental disorders, musculoskeletal disorders and income-driven patterns: Evidence from the global burden of disease study 2017. Journal of Clinical Medicine Research, 9(7), 2189. https:\/\/doi.org\/10.3390\/jcm9072189","journal-title":"Journal of Clinical Medicine Research"},{"issue":"March","key":"4_CR80","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.schres.2019.05.028","volume":"217","author":"HC van Mierlo","year":"2020","unstructured":"van Mierlo, H. C., Schot, A., Boks, M. P. M., & de Witte, L. D. (2020). The Association between Schizophrenia and the immune system: review of the evidence from unbiased \u2018omic-studies. Schizophrenia Research, 217(March), 114\u2013123.","journal-title":"Schizophrenia Research"},{"issue":"3","key":"4_CR81","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/wps.20252","volume":"14","author":"D Vancampfort","year":"2015","unstructured":"Vancampfort, D., Stubbs, B., Mitchell, A. J., De Hert, M., Wampers, M., Ward, P. B., Rosenbaum, S., & Correll, C. U. (2015). Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: A systematic review and meta-analysis. World Psychiatry, 14(3), 339\u2013347.","journal-title":"World Psychiatry"},{"key":"4_CR82","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3389\/fnins.2015.00297","volume":"9","author":"A Ventriglio","year":"2015","unstructured":"Ventriglio, A., Gentile, A., Stella, E., & Bellomo, A. (2015). Metabolic issues in patients affected by schizophrenia: Clinical characteristics and medical management. Frontiers in Neuroscience, 9, 297. https:\/\/doi.org\/10.3389\/fnins.2015.00297","journal-title":"Frontiers in Neuroscience"},{"issue":"4","key":"4_CR83","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/sj.npp.1301142","volume":"32","author":"HS Vestri","year":"2007","unstructured":"Vestri, H. S., Maianu, L., Moellering, D. R., & Timothy Garvey, W. (2007). Atypical antipsychotic drugs directly impair insulin action in adipocytes: Effects on glucose transport, lipogenesis, and Antilipolysis. Neuropsychopharmacology, 32(4), 765\u2013772.","journal-title":"Neuropsychopharmacology"},{"key":"4_CR84","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3389\/fphar.2020.00394","volume":"11","author":"PM Vidal","year":"2020","unstructured":"Vidal, P. M., & Pacheco, R. (2020). The cross-talk between the dopaminergic and the immune system involved in schizophrenia. Frontiers in Pharmacology, 11, 394. https:\/\/doi.org\/10.3389\/fphar.2020.00394","journal-title":"Frontiers in Pharmacology"},{"issue":"9","key":"4_CR85","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1590\/S1807-59322010000900012","volume":"65","author":"M von Wilmsdorff","year":"2010","unstructured":"von Wilmsdorff, M., Bouvier, M.-L., Henning, U., Schmitt, A., & Gaebel, W. (2010). The impact of antipsychotic drugs on food intake and body weight and on leptin levels in blood and hypothalamic Ob-R leptin receptor expression in Wistar rats. Clinics, 65(9), 885\u2013894.","journal-title":"Clinics"},{"issue":"December","key":"4_CR86","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cortex.2020.09.017","volume":"133","author":"S Walther","year":"2020","unstructured":"Walther, S., Mittal, V. A., Stegmayer, K., & Bohlhalter, S. (2020). Gesture Deficits and Apraxia in Schizophrenia. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior, 133(December), 65\u201375.","journal-title":"Cortex; a Journal Devoted to the Study of the Nervous System and Behavior"},{"issue":"5","key":"4_CR87","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1093\/schbul\/sbx091","volume":"43","author":"S Walther","year":"2017","unstructured":"Walther, S., Stegmayer, K., Federspiel, A., Bohlhalter, S., Wiest, R., & Viher, P. V. (2017). Aberrant Hyperconnectivity in the motor system at rest is linked to motor abnormalities in schizophrenia spectrum disorders. Schizophrenia Bulletin, 43(5), 982\u2013992.","journal-title":"Schizophrenia Bulletin"},{"issue":"2","key":"4_CR88","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1159\/000339456","volume":"66","author":"S Walther","year":"2012","unstructured":"Walther, S., & Strik, W. (2012). Motor symptoms and schizophrenia. Neuropsychobiology, 66(2), 77\u201392.","journal-title":"Neuropsychobiology"},{"issue":"2","key":"4_CR89","doi-asserted-by":"publisher","first-page":"848","DOI":"10.4049\/jimmunol.176.2.848","volume":"176","author":"Y Watanabe","year":"2006","unstructured":"Watanabe, Y., Nakayama, T., Nagakubo, D., Hieshima, K., Jin, Z., Katou, F., Hashimoto, K., & Yoshie, O. (2006). Dopamine selectively induces migration and homing of naive CD8+ T cells via dopamine receptor D3. Journal of Immunology, 176(2), 848\u2013856.","journal-title":"Journal of Immunology"},{"issue":"10","key":"4_CR90","doi-asserted-by":"publisher","first-page":"856","DOI":"10.4088\/JCP.v63n1002","volume":"63","author":"DA Wirshing","year":"2002","unstructured":"Wirshing, D. A., Boyd, J. A., Meng, L. R., Ballon, J. S., Marder, S. R., & Wirshing, W. C. (2002). The effects of novel antipsychotics on glucose and lipid levels. The Journal of Clinical Psychiatry, 63(10), 856\u2013865.","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"4","key":"4_CR91","first-page":"304","volume":"24","author":"AL Wolff","year":"1999","unstructured":"Wolff, A. L., & O\u2019Driscoll, G. A. (1999). Motor deficits and schizophrenia: The evidence from neuroleptic-Na\u00efve patients and populations at risk. Journal of Psychiatry & Neuroscience, 24(4), 304\u2013314.","journal-title":"Journal of Psychiatry & Neuroscience"},{"issue":"2","key":"4_CR92","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/s41593-020-00763-8","volume":"24","author":"M Yilmaz","year":"2021","unstructured":"Yilmaz, M., Yalcin, E., Presumey, J., Aw, E., Ma, M., Whelan, C. W., Stevens, B., McCarroll, S. A., & Carroll, M. C. (2021). Overexpression of schizophrenia susceptibility factor human complement C4A promotes excessive synaptic loss and behavioral changes in mice. Nature Neuroscience, 24(2), 214\u2013224.","journal-title":"Nature Neuroscience"},{"issue":"March","key":"4_CR93","doi-asserted-by":"publisher","first-page":"113098","DOI":"10.1016\/j.bbr.2020.113098","volume":"402","author":"K Yoshida","year":"2021","unstructured":"Yoshida, K., & Takeuchi, H. (2021). Dose-dependent effects of antipsychotics on efficacy and adverse effects in schizophrenia. Behavioural Brain Research, 402(March), 113098.","journal-title":"Behavioural Brain Research"},{"issue":"July","key":"4_CR94","first-page":"702720","volume":"12","author":"Q Zhang","year":"2021","unstructured":"Zhang, Q., He, H., Bai, X., Jiang, L., Chen, W., Zeng, X., Li, Y., Teixeira, A. L., & Dai, J. (2021). Unveiling the metabolic profile of first-episode drug-Na\u00efve schizophrenia patients: Baseline characteristics of a longitudinal study among Han Chinese. Frontiers in Psychiatry\/Frontiers Research Foundation, 12(July), 702720.","journal-title":"Frontiers in Psychiatry\/Frontiers Research Foundation"},{"issue":"February","key":"4_CR95","doi-asserted-by":"publisher","first-page":"105061","DOI":"10.1016\/j.psyneuen.2020.105061","volume":"124","author":"Y Zhou","year":"2021","unstructured":"Zhou, Y., Song, X., Guo, Y., Lang, X., Li, Z., & Zhang, X. Y. (2021). Sex differences in metabolic disorder patterns of first-episode drug-naive patients with schizophrenia. Psychoneuroendocrinology, 124(February), 105061.","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"4_CR96","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/nn1629","volume":"9","author":"Y Ziv","year":"2006","unstructured":"Ziv, Y., Ron, N., Butovsky, O., Landa, G., Sudai, E., Greenberg, N., Cohen, H., Kipnis, J., & Schwartz, M. (2006). Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nature Neuroscience, 9(2), 268\u2013275.","journal-title":"Nature Neuroscience"}],"container-title":["Advances in Experimental Medicine and Biology","Neuroproteomics as a Tool for Understanding Schizophrenia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-97182-3_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T10:52:23Z","timestamp":1660560743000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-97182-3_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9783030971816","9783030971823"],"references-count":96,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-97182-3_4","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"6 August 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}